500
Participants
Start Date
November 26, 2019
Primary Completion Date
December 31, 2043
Study Completion Date
December 31, 2043
Metformin TEVA 850 mg
At inclusion, patients (N=500) will be randomized 1:1 to metformin vs usual care (850 mg tablets, 3 times daily or, if tolerance is suboptimal, a lower maximally tolerated dose, 1-2 times daily), on top of diet and lifestyle, with an insulin rescue in both arms if needed.
RECRUITING
Martini hospital Groningen, Groningen
RECRUITING
University Medical Center Groningen, Groningen
RECRUITING
Treant Zorggroep, Hoogenveen, Emmen, Stadskanaal
RECRUITING
Medical Center Leeuwarden, Leeuwarden
Maastricht University Medical Center
OTHER
University Medical Center Groningen
OTHER
Frisius Medisch Centrum
OTHER
Martini Hospital Groningen
OTHER
Treant Zorggroep
UNKNOWN
Nij Smellinghe Hosptial
OTHER
Bethesda Diabetes Research Center
OTHER